Goldman Sachs’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
Other funds holding ZBH
VCM
VPM
Goldman Sachs's ZBH Position: Q1 2026 in Review
Goldman Sachs increased its Zimmer Biomet (ZBH) stake by 6.9% in Q1 2026, buying an estimated $6.4M and bringing the position to 1,088,213 shares worth $98.4M. The position accounts for 0.01% of the portfolio, ranked #1042.
Goldman Sachs first reported a position in ZBH in Q2 2013 and has held it in 52 quarters since. The position peaked at $3.52B in Q2 2015. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.
- Goldman Sachs held 1,088,213 shares of Zimmer Biomet worth $98.4M as of Q1 2026.
- Goldman Sachs bought 69,794 Zimmer Biomet shares in Q1 2026, an estimated $6.4M.
- Zimmer Biomet made up 0.01% of Goldman Sachs's portfolio in Q1 2026, its #1042 holding.
- Goldman Sachs first reported a position in Zimmer Biomet in Q2 2013 and has held it in 52 quarters since.
- Goldman Sachs's Zimmer Biomet position peaked at $3.52B in Q2 2015.
- 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.
Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.